ELI LILLY & Co — Director's Dealing 2024

Mar 11, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-02-12

Reporting Person: Zakrowski Donald A (SVP, Finance, & CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-11	Common Stock	S	750	$753.60	Disposed	7880	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-12	Restricted Stock Unit	$	A	184	Acquired	2026-02-16	Common Stock (184)	Direct
2024-02-12	Restricted Stock Unit	$	A	186	Acquired	2027-02-16	Common Stock (186)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1710	Indirect

Footnotes

F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.

F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. These grants were inadvertently omitted from the reporting person's Form 4 filed on February 14, 2024.